FGF21, fibroblast growth factor 21, 26291

N. diseases: 236; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.030 Biomarker disease BEFREE FGF21 promoted lipolysis in adipose tissue and led to hyperlipidemia and decreased body weight. 31586035 2019
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.030 Biomarker disease BEFREE Multivariate linear regression analysis showed that cTnI (β = -0.001, 95% CI = 0.021-0.001, P = 0.002), fibrinogen (β = -0.055, 95% CI = 0.098-0.013, P = 0.011) and hyperlipidemia (β = 0.129, 95% CI = 0.014-0.243, P = 0.011) were the independent risk factors for the serum of FGF21 in AMI patients. 30323882 2018
CUI: C0020473
Disease: Hyperlipidemia
Hyperlipidemia
0.030 Biomarker disease BEFREE A large amount of data, predominantly obtained from murine models but also from non-human primates, suggest that FGF21 ameliorates obesity-associated hyperglycemia and hyperlipidemia primarily via effects on adipose tissue and the pancreas. 19277467 2009